Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Revenue | 22.94bn | 16.82bn | 13.06bn | 12.45bn |
| Cost of revenue | 12.69bn | 9.61bn | 7.23bn | 7.26bn |
| Gross profit | 10.24bn | 7.21bn | 5.83bn | 5.19bn |
| Research and development | 1.16bn | 1.21bn | 1.16bn | 1.38bn |
| Selling, general and administrative | 1.36bn | 1.27bn | 1.13bn | 1.44bn |
| Operating expenses | 8.26bn | 6.54bn | 5.61bn | 6.67bn |
| Operating income | 1.99bn | 662m | 225m | −1.49bn |
| Interest expense | 34m | 38m | 41m | 45m |
| Pre-tax income | 2.28bn | 779m | 432m | −1.50bn |
| Income tax | 651m | 321m | 263m | 168m |
| Net income | 1.58bn | 444m | 151m | −1.65bn |
| Earnings per share | 2.65 | 0.77 | 0.27 | −2.96 |
| Earnings per share, diluted | 2.52 | 0.74 | 0.25 | −2.96 |
| Weighted average shares | 595m | 575m | 567m | 558m |
| Weighted average shares, diluted | 638m | 605m | 594m | 558m |
| Metric | Aug 19, 2026 | Aug 18, 2026 | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | 4.16bn | 2.41bn | 2.81bn | 7.61bn | 10.84bn |
| Short-term investments | — | — | 6.41bn | 6.22bn | 2.55bn | — | — |
| Receivables | — | — | 378m | 307m | 263m | — | — |
| Inventory | — | — | 223m | 143m | 125m | — | — |
| Current assets | — | — | 23.25bn | 16.86bn | 11.77bn | — | — |
| Property, plant and equipment | — | — | 1.31bn | 1.10bn | 1.21bn | — | — |
| Goodwill | — | — | 104m | 108m | 113m | 230m | — |
| Total assets | — | — | 29.37bn | 22.63bn | 18.88bn | — | — |
| Current liabilities | — | — | 14.68bn | 11.30bn | 8.17bn | — | — |
| Total liabilities | — | — | 16.72bn | 14.15bn | 12.19bn | — | — |
| Equity | — | — | 12.53bn | 8.37bn | 6.59bn | 5.81bn | 7.42bn |
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Operating cash flow | 5.02bn | 3.28bn | 2.08bn | −1.06bn |
| Depreciation and amortisation | 372m | 390m | 441m | 428m |
| Share-based compensation | 625m | 716m | 685m | 706m |
| Capital expenditure | 514m | 318m | 242m | 924m |
| Investing cash flow | −4.41bn | −5.04bn | −5.80bn | −2.43bn |
| Share buybacks | 14m | 0 | 0 | — |
| Financing cash flow | 1.62bn | 1.68bn | 366m | 400m |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)